نتایج جستجو برای: fabry disease

تعداد نتایج: 1493456  

2016
Gisela Kalkum Susanne Pitz Nesrin Karabul Michael Beck Guillem Pintos-Morell Rossella Parini Marianne Rohrbach Svetlana Bizjajeva Uma Ramaswami

BACKGROUND Ocular signs of Fabry disease can be seen in the first decade of life. METHODS We examined the occurrence of ocular signs in 232 paediatric patients in the Fabry Outcome Survey (FOS) international registry and looked for relationships between the presence of eye findings and disease severity as measured by the FOS Mainz severity score index (FOS-MSSI). RESULTS At least one ocular...

Journal: :Journal of Cardiovascular Medicine 2018

Journal: :Journal of the American Society of Nephrology : JASN 2004
Peter Kotanko Reinhard Kramar Danijela Devrnja Eduard Paschke Till Voigtländer Martin Auinger Severo Pagliardini Marco Spada Klaus Demmelbauer Matthias Lorenz Anna-Christine Hauser Hans-Jörg Kofler Karl Lhotta Ulrich Neyer Wolfgang Pronai Manfred Wallner Clemens Wieser Martin Wiesholzer Herbert Zodl Manuela Födinger Gere Sunder-Plassmann

Anderson-Fabry disease is possibly underdiagnosed in patients with end-stage renal disease. Nationwide screening was therefore undertaken for Anderson-Fabry disease among dialysis patients in Austria. Screening for alpha-galactosidase A (AGAL) deficiency was performed by a blood spot test. In patients with a positive screening test, AGAL activity in leukocytes was determined. Individuals with d...

2015
Hideaki Sueoka Junji Ichihara Takahiro Tsukimura Tadayasu Togawa Hitoshi Sakuraba

Biomarkers useful for diagnosis and evaluation of treatment for patients with Fabry disease are urgently needed. Recently, plasma globotriaosylsphingosine (lyso-Gb3) and lyso-Gb3-related analogues have attracted attention as promising biomarkers of Fabry disease. However, the plasma concentrations of lyso-Gb3 and its analogues are extremely low or below the detection limits in some Fabry patien...

Journal: :American journal of hypertension 2006
Julia Kleinert François Dehout Andreas Schwarting Abelardo García de Lorenzo Roberta Ricci Christoph Kampmann Michael Beck Uma Ramaswami Ales Linhart Andreas Gal Gunnar Houge Urs Widmer Atul Mehta Gere Sunder-Plassmann

BACKGROUND Fabry disease is a rare X-linked disease arising from deficiency of alpha-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disea...

2013
Tomás Segura Oscar Ayo-Martín Isabel Gómez-Fernandez Carolina Andrés Miguel A Barba José Vivancos

BACKGROUND Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy controls. METHODS Cerebral hemodynamics, vascular remodelling and systemic endothelial function wer...

Journal: :Deutsches Arzteblatt international 2009
Björn Hoffmann Ertan Mayatepek

BACKGROUND Data obtained from screened newborns and from persons at known risk for Fabry disease suggest that this condition is much more common in Germany than previously assumed. Its clinical manifestations are very diverse, and its differential diagnosis is correspondingly broad. Thus, there is often a delay before the diagnosis of Fabry disease is established. METHODS Selective literature...

2011
Andreas D. Kistler Justyna Siwy Frank Breunig Praveen Jeevaratnam Alexander Scherl William Mullen David G. Warnock Christoph Wanner Derralynn A. Hughes Harald Mischak Rudolf P. Wüthrich Andreas L. Serra

Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase A gene, is available and no biomarker has been proven useful to screen for the disease, predict disease course and monitor response to enzyme repl...

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2013
Hiroki Maruyama Takuma Takata Yutaka Tsubata Ryushi Tazawa Kiyoe Goto Jun Tohyama Ichiei Narita Hidekatsu Yoshioka Satoshi Ishii

BACKGROUND AND OBJECTIVES Previous reports of Fabry disease screening in dialysis patients indicate that α-galactosidase A activity alone cannot specifically and reliably identify appropriate candidates for genetic testing; a marker for secondary screening is required. Elevated plasma globotriaosylsphingosine is reported to be a hallmark of classic Fabry disease. The purpose of this study was t...

2010
Marieke Biegstraaten Ivo N van Schaik Wouter Wieling Frits A Wijburg Carla EM Hollak

BACKGROUND Fabry patients have symptoms and signs compatible with autonomic dysfunction. These symptoms and signs are considered to be due to impairment of the peripheral nervous system, but findings indicative of autonomic neuropathy in other diseases, such as orthostatic intolerance and male sexual dysfunction, are infrequently reported in Fabry disease. The aim of our study was to investigat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید